These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32648069)

  • 21. Levosimendan versus intra-aortic balloon pump in high-risk cardiac surgery patients.
    Severi L; Lappa A; Landoni G; Di Pirro L; Luzzi SJ; Caravetta P; Cipullo P; Menichetti A
    J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):632-6. PubMed ID: 21546269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    Mehta RH; Leimberger JD; van Diepen S; Meza J; Wang A; Jankowich R; Harrison RW; Hay D; Fremes S; Duncan A; Soltesz EG; Luber J; Park S; Argenziano M; Murphy E; Marcel R; Kalavrouziotis D; Nagpal D; Bozinovski J; Toller W; Heringlake M; Goodman SG; Levy JH; Harrington RA; Anstrom KJ; Alexander JH;
    N Engl J Med; 2017 May; 376(21):2032-2042. PubMed ID: 28316276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
    Zangrillo A; Alvaro G; Pisano A; Guarracino F; Lobreglio R; Bradic N; Lembo R; Gianni S; Calabrò MG; Likhvantsev V; Grigoryev E; Buscaglia G; Pala G; Auci E; Amantea B; Monaco F; De Vuono G; Corcione A; Galdieri N; Cariello C; Bove T; Fominskiy E; Auriemma S; Baiocchi M; Bianchi A; Frontini M; Paternoster G; Sangalli F; Wang CY; Zucchetti MC; Biondi-Zoccai G; Gemma M; Lipinski MJ; Lomivorotov VV; Landoni G
    Am Heart J; 2016 Jul; 177():66-73. PubMed ID: 27297851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Levosimendan in Postoperative Setting After Surgical Repair of Congenital Heart Disease in Children.
    Amiet V; Perez MH; Longchamp D; Boulos Ksontini T; Natterer J; Plaza Wuthrich S; Cotting J; Di Bernardo S
    Pediatr Cardiol; 2018 Jan; 39(1):19-25. PubMed ID: 28884218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic use of levosimendan in preoperative setting for surgical repair of congenital heart disease in children.
    Wannaz L; Boillat L; Perez MH; Di Bernardo S
    Front Pediatr; 2023; 11():1205971. PubMed ID: 37539009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Elevated Low Cardiac Output Syndrome Score Is Associated With Morbidity in Infants After Congenital Heart Surgery.
    Ulate KP; Yanay O; Jeffries H; Baden H; Di Gennaro JL; Zimmerman J
    Pediatr Crit Care Med; 2017 Jan; 18(1):26-33. PubMed ID: 28060152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
    Mishra A; Kumar B; Dutta V; Arya VK; Mishra AK
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):639-46. PubMed ID: 27321790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing Risk Factors for Prolonged Intensive Care Unit Stay After Surgery for Adult Congenital Heart Disease: A Study From a Lower-Middle-Income Country.
    Martins RS; Waqar U; Raza HA; Memon MKY; Akhtar S
    Cureus; 2023 Feb; 15(2):e35606. PubMed ID: 37007353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levosimendan in cardiac surgery.
    Siirilä-Waris K; Suojaranta-Ylinen R; Harjola VP
    J Cardiothorac Vasc Anesth; 2005 Jun; 19(3):345-9. PubMed ID: 16130062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.
    Mehta RH; Van Diepen S; Meza J; Bokesch P; Leimberger JD; Tourt-Uhlig S; Swartz M; Parrotta J; Jankowich R; Hay D; Harrison RW; Fremes S; Goodman SG; Luber J; Toller W; Heringlake M; Anstrom KJ; Levy JH; Harrington RA; Alexander JH;
    Am Heart J; 2016 Dec; 182():62-71. PubMed ID: 27914501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study).
    Caruba T; Hourton D; Sabatier B; Rousseau D; Tibi A; Hoffart-Jourdain C; Souag A; Freitas N; Yjjou M; Almeida C; Gomes N; Aucouturier P; Djadi-Prat J; Menasché P; Chatellier G; Cholley B
    J Cardiothorac Surg; 2016 Aug; 11(1):127. PubMed ID: 27496105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative levosimendan in ischemic mitral valve repair.
    Sharma P; Malhotra A; Gandhi S; Garg P; Bishnoi A; Gandhi H
    Asian Cardiovasc Thorac Ann; 2014 Jun; 22(5):539-45. PubMed ID: 24867027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levosimendan for patients with heart failure undergoing major oncological surgery: A randomised blinded pilot study.
    Shaker EH; Hussein K; Reyad EM
    Indian J Anaesth; 2019 Dec; 63(12):1001-1007. PubMed ID: 31879424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful use of levosimendan as a primary inotrope in pediatric cardiac surgery: An observational study in 110 patients.
    Joshi RK; Aggarwal N; Aggarwal M; Pandey R; Dinand V; Joshi R
    Ann Pediatr Cardiol; 2016; 9(1):9-15. PubMed ID: 27011685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Levosimendan on Renal Outcome in Cardiac Surgery Patients With Chronic Kidney Disease and Perioperative Cardiovascular Dysfunction: A Substudy of a Multicenter Randomized Trial.
    Zangrillo A; Alvaro G; Belletti A; Pisano A; Brazzi L; Calabrò MG; Guarracino F; Bove T; Grigoryev EV; Monaco F; Boboshko VA; Likhvantsev VV; Scandroglio AM; Paternoster G; Lembo R; Frassoni S; Comis M; Pasyuga VV; Navalesi P; Lomivorotov VV;
    J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2152-2159. PubMed ID: 29580796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levosimendan for Perioperative Cardioprotection: Myth or Reality?
    Santillo E; Migale M; Massini C; Incalzi RA
    Curr Cardiol Rev; 2018; 14(3):142-152. PubMed ID: 29564979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early levosimendan administration is associated with decreased mortality after cardiac surgery.
    Treskatsch S; Balzer F; Geyer T; Spies CD; Kastrup M; Grubitzsch H; Wernecke KD; Erb JM; Braun JP; Sander M
    J Crit Care; 2015 Aug; 30(4):859.e1-6. PubMed ID: 25837801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.
    Lechner E; Moosbauer W; Pinter M; Mair R; Tulzer G
    Pediatr Crit Care Med; 2007 Jan; 8(1):61-3. PubMed ID: 17149153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic application of levosimendan in cardiac surgical patients with severe left ventricle dysfunction.
    Brezina A; Riha H; Pirk J
    Exp Clin Cardiol; 2009; 14(2):e31-4. PubMed ID: 19675817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.